156 related articles for article (PubMed ID: 38051513)
21. Role of somatostatin analogues in the treatment of neuroendocrine tumors.
Narayanan S; Kunz PL
J Natl Compr Canc Netw; 2015 Jan; 13(1):109-17; quiz 117. PubMed ID: 25583773
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
Öberg K; Lamberts SW
Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
[TBL] [Abstract][Full Text] [Related]
23. Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors.
Narayanan S; Kunz PL
Hematol Oncol Clin North Am; 2016 Feb; 30(1):163-77. PubMed ID: 26614375
[TBL] [Abstract][Full Text] [Related]
24. Management of late biliary complications in patients with gallbladder stones in situ after endoscopic papillary balloon dilation.
Tsujino T; Kawabe T; Isayama H; Yashima Y; Yagioka H; Kogure H; Sasaki T; Arizumi T; Togawa O; Ito Y; Matsubara S; Nakai Y; Sasashira N; Hirano K; Tada M; Omata M
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):376-80. PubMed ID: 20611007
[TBL] [Abstract][Full Text] [Related]
25. The management of gastroenteropancreatic neuroendocrine tumors with somatostatin analogues.
Khagi S; Saif MW
JOP; 2014 Jul; 15(4):295-8. PubMed ID: 25076324
[TBL] [Abstract][Full Text] [Related]
26. Management of late biliary complications in patients with gallbladder stones in situ after endoscopic papillary balloon dilation.
Tsujino T; Kawabe T; Isayama H; Yashima Y; Yagioka H; Kogure H; Sasaki T; Arizumi T; Togawa O; Ito Y; Matsubara S; Nakai Y; Sasashira N; Hirano K; Tada M; Omata M
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):466-70. PubMed ID: 19382302
[TBL] [Abstract][Full Text] [Related]
27. Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report.
Skalický A; Vištejnová L; Dubová M; Malkus T; Skalický T; Troup O
World J Surg Oncol; 2019 Mar; 17(1):55. PubMed ID: 30902091
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
Merola E; Panzuto F; Delle Fave G
Oncotarget; 2017 Jul; 8(28):46624-46634. PubMed ID: 28402955
[TBL] [Abstract][Full Text] [Related]
29. Clinical effectiveness and cost-effectiveness of cholecystectomy compared with observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation.
Brazzelli M; Cruickshank M; Kilonzo M; Ahmed I; Stewart F; McNamee P; Elders A; Fraser C; Avenell A; Ramsay C
Health Technol Assess; 2014 Aug; 18(55):1-101, v-vi. PubMed ID: 25164349
[TBL] [Abstract][Full Text] [Related]
30. INITIATION OF PATIENTS ONTO LONG-ACTING SOMATOSTATIN ANALOGUE THERAPY FOR NEUROENDOCRINE TUMORS: A SINGLE-CENTER REVIEW OF PRACTICE.
Tadman M; Charlton P; Jafar-Mohammadi B; Talbot D; Grossman AB
Endocr Pract; 2018 Feb; 24(2):189-194. PubMed ID: 29466059
[TBL] [Abstract][Full Text] [Related]
31. [Complete and sustained remission of liver metastases from neuroendocrine tumor with somatostatin analogue therapy].
Raizer G; Igaz P; Pregun I; Dabasi G; Rácz K
Orv Hetil; 2011 Mar; 152(10):407-10. PubMed ID: 21354958
[TBL] [Abstract][Full Text] [Related]
32. When and How to Use Somatostatin Analogues.
de Herder WW
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):549-555. PubMed ID: 30098715
[TBL] [Abstract][Full Text] [Related]
33. Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs.
Igarashi H; Hijioka M; Lee L; Ito T
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):618-22. PubMed ID: 25689143
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs and Treatment with Somatostatin Analogs in Gastro- Entero-Pancreatic Neuroendocrine Neoplasms: Challenges in Personalized Medicine.
Curt AM; Popa Ilie IR; Cainap C; Balacescu O; Ghervan C
J Gastrointestin Liver Dis; 2020 Dec; 29(4):647-659. PubMed ID: 33331339
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic Cholecystectomy at Time of Surgery for Small Bowel Neuroendocrine Tumor Does Not Increase Postoperative Morbidity.
Sinnamon AJ; Neuwirth MG; Vining CC; Sharoky CE; Yang YX; Kelz RR; Fraker DL; Roses RE; Karakousis GC
Ann Surg Oncol; 2018 Jan; 25(1):239-245. PubMed ID: 29067602
[TBL] [Abstract][Full Text] [Related]
36. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
Grozinsky-Glasberg S; Grossman AB; Korbonits M
Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options.
Merola E; Prasad V; Pascher A; Pape UF; Arsenic R; Denecke T; Fehrenbach U; Wiedenmann B; Pavel ME
Neuroendocrinology; 2020; 110(6):517-524. PubMed ID: 31484182
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic cholecystectomy for the various types of gallbladder inflammation: a prospective trial.
Eldar S; Sabo E; Nash E; Abrahamson J; Matter I
Surg Laparosc Endosc; 1998 Jun; 8(3):200-7. PubMed ID: 9649044
[TBL] [Abstract][Full Text] [Related]
39. Analysis of gallstone disease after gastric cancer surgery.
Liang TJ; Liu SI; Chen YC; Chang PM; Huang WC; Chang HT; Chen IS
Gastric Cancer; 2017 Sep; 20(5):895-903. PubMed ID: 28154944
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic cholecystectomy for acute cholecystitis: prospective trial.
Eldar S; Sabo E; Nash E; Abrahamson J; Matter I
World J Surg; 1997 Jun; 21(5):540-5. PubMed ID: 9204745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
